Skip to main content

Immune globulin intravenous for Chronic Inflammatory Demyelinating Polyradiculoneuropathy User Reviews

Brand names: Privigen, Octagam, Panzyga, Gammagard S/D, Gammaplex, Asceniv, Bivigam, Alyglo, Flebogamma, Yimmugo, Carimune NF …show all brand names

Rating: 7.3

Immune globulin intravenous has an average rating of 7.3 out of 10 from a total of 3 reviews for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy. 33% of reviewers reported a positive experience, while 0% reported a negative experience.

10
0%
9
33%
8
0%
7
33%
6
33%
5
0%
4
0%
3
0%
2
0%
1
0%
  • 104...
  • Taken for less than 1 month
  • May 15, 2023

Immune globulin intravenous "Three days after completing the first three-day treatment, seem to have very modest improvement in balance. Have had very mild headache helped by drinking plenty of water and have experienced some fatigue. So far, benefits outweigh the side effects."

7 / 10
Was this helpful?YesNo
6 Report
  • Art...
  • Taken for 6 months to 1 year
  • March 13, 2025

Immune globulin intravenous "It helps with my dizziness, balance problems, and tremors. I just wish the doctor knew how to prescribe it. He prescribes it for five days every three months. Panzyga starts wearing off at two weeks. The medication itself only lasts 25 days. I was on IVIG from age 10-18. It worked really well. I took it every two weeks for two days. Side effects: headache and nausea last about 8-9 days. I am a really hard stick, and it’s hard to keep an IV in me."

9 / 10
Was this helpful?YesNo
0 Report
  • Ali...
  • Taken for 2 to 5 years
  • September 2, 2022

"I’m receiving 45g every 3 weeks, but the Panzega only lasts a short time well before the next treatment."

6 / 10
Was this helpful?YesNo
1 Report

Are you taking this medicine?

Your review helps others make informed decisions.
Write a review
Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.

Learn more about Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Care guides